Drug Discovery and the Market Today Part 3: The Focus on Solubility

• Drug Discovery and the Market Today Part 4: Developing Amorphous Forms

• Drug Discovery and the Market Today Part 5: Considering Genotoxic and Carcinogenic Impurities

• Drug Discovery and the Market Today: Video Exclusive with Dr. David Elder, GSK

• BHC- Product Supply: Pipeline Transparency & Risk Asssessment

• Recent Developments in Optimised Forecast Accuracy, Sales and Operations Planning at Merck Serono

• Drug Discovery and the Market Today Part 2: Critical Thoughts on Stability

• Drug Discovery and the Market Today Part 1: An Overview of Externalisation in the Pharma Industry

• Implementing a Systematic and Transparent Approach to Post Approval Surveillance and Continued Safety Monitoring

• Vaccines and Pharmacovigilance: Meeting the Challenges in a Pandemic Situation

• Pharmacovigilance and Risk Management: Getting to Grips with the Evolving Regulatory Environment

* = required.